Literature DB >> 31135817

Error in Table.

.   

Abstract

Year:  2019        PMID： 31135817      PMCID： PMC6547102          DOI： 10.1001/jamaneurol.2019.1177

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  1 in total

1.  Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

Authors:  Virginia L Stauffer; David W Dodick; Qi Zhang; Jeffrey N Carter; Jessica Ailani; Robert R Conley
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.